Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

Summary

The purpose of this study is to evaluate the efficacy of NBI-1065845 compared with placebo in participants with MDD on improving symptoms of depression.

Timeline

Start

2022-02-21

Primary completion

2024-01-10

Completion

2024-02-21

Drugs

Indications